Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. (Q37572815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

Bénédicte Puissant-Lubrano

4 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

O Milioto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

L Esposito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

M C Pierre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

A Ould Mohamed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

L Lavayssière

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

O Cointault

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

D Ribes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

I Cardeau

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

M B Nogier

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

D Durand

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

M Abbal

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

A Blancher

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

L Rostaing

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

28 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

89-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19656128%20AND%20SRC:MED&resulttype=core&format=json

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

The mechanisms of action of rituximab in the elimination of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

A review of the current use of rituximab in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab as treatment for refractory kidney transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Overcoming a positive crossmatch in living-donor kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Tolerability and safety of rituximab (MabThera).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

The effects of rituximab on immunocompetency in patients with autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

HIV-associated lymphoma: promising new results, but with toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Impact of rituximab therapy for treatment of acute humoral rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X

Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02785.X